← All trials
NCT05211557
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 16, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Aug 31, 2026
- First posted
- Jan 27, 2022
- Last posted
- Jan 27, 2022
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Xuzhou Medical UniversityLead sponsor
- Xuzhou Medical UniversityOverall official - principal investigator
- Xuzhou Medical UniversityCollaborator
- Xuzhou Medical UniversityOverall official - principal investigator
- Xuzhou Medical UniversityOfficial
- Xuzhou Medical UniversityOfficial
- Xuzhou Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.